Thomas Fekete, MD, Chair and Professor in the Department of Medicine and Professor of Microbiology and Immunology at the Lewis Katz School of Medicine at Temple University, provided commentary to the Philadelphia Inquirer on fosfomycin (Contepo), an antibiotic that has been used in hospitals in Europe and Asia but not in the United States – yet. The drug is awaiting U.S. Food and Drug Administration approval.
Important announcement concerning Temple Health and Keystone First. Our provider agreement with Keystone First is scheduled to end on July 31st. Click the link below to learn about your options for continuing care at Temple Health.
Learn More
800-TEMPLE-MED
Schedule Appointment
SEARCH TEMPLE HEALTH